Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination.
Efficacy of ABX196, a new NKT agonist, in prophylactic human vaccination. Vaccine. 2014 Oct 21; 32(46):6138-45.
View in:
PubMed
subject areas
Adjuvants, Immunologic
Adult
Animals
Double-Blind Method
Galactosylceramides
Hepatitis B
Hepatitis B Antibodies
Hepatitis B Surface Antigens
Hepatitis B Vaccines
Humans
Interferon-gamma
Macaca fascicularis
Male
Mice
Molecular Structure
Natural Killer T-Cells